Oxxon Therapeutics - acquired by oxford biomedica plc
the company was spun-out from the Nuffield Department of Clinical Medicine at the University of Oxford to exploit the patented heterologous primeboost technology for development of therapeutic vaccines. Oxxon was acquired by Oxford BioMedica in March 2007.